Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1996
11/13/1996CN1135483A Quinoxaline and preparation method and application thereof
11/13/1996CN1135480A Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound
11/13/1996CN1135358A Medicine for treatment of restenosis and arteriosclerosis
11/13/1996CN1135348A Bezoar powder for treatment of cervical disease and preparation method thereof
11/13/1996CN1135334A Six chemical compositions for treatment of giving up opiomania drug-taking and preparation method thereof
11/13/1996CN1135333A Usage of SRCSH2 specific compound for treatment of bone absorption disease
11/13/1996CN1135332A Local therapy for skin virus infection
11/13/1996CN1135290A Nutrious milk powder
11/13/1996CN1033273C New erythromycin derivatives their preparation process and their use as medicaments
11/12/1996US5574190 Naphthyl compounds, intermediates, compositions, and methods
11/12/1996US5574177 Breast cancer
11/12/1996US5574173 Inhibitors of tumor necrosis factor
11/12/1996US5574170 Ketorolac derivatives with considerably reduced gastro-intestinal irritation and ulceration
11/12/1996US5574168 1-(substituted benzyl)-3-(substituted aryl)-condensed pyrazole derivatives and processes of making the same
11/12/1996US5574167 Alkanoic and benzoic esters of 1-(2-hydroxypropyl)-2-methyl-5-nitromoimidazole
11/12/1996US5574164 1-alkyl-,1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds
11/12/1996US5574161 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)quinolonecarboxylic and 7-(aminomethyl-oxa-7-aza-bicyclo[3.3.0]oct-7-yl naphthyridonecarboxylic acid derivatives
11/12/1996US5574158 Crypt compounds, nervous system disorders, chelate compounds
11/12/1996US5574156 N-carbonyl azetidin-2-ones
11/12/1996US5574153 Bactericides
11/12/1996US5574151 Process for the preparation of sennosides A and B
11/12/1996US5574149 Method of treating HIV infections with 2',3'-dideoxy-3'-fluoro-5-chlorouridine
11/12/1996US5574071 Administering phenylalkylamino ketones
11/12/1996US5574070 Substituted guanidines having high binding to the sigma receptor and the use thereof
11/12/1996US5574069 Substituted benzenesulfonylureas and -thioureas- process for their preparation and their use as pharmaceuticals
11/12/1996US5574067 Method of treating wrinkles using gluconic acid or gluconolactone
11/12/1996US5574066 Intraocular pressure reducing 15-acyl prostaglandins
11/12/1996US5574065 Method and composition for normalizing injury response
11/12/1996US5574060 Selective inhibitors of biogenic amine transporters
11/12/1996US5574059 Treating disorders mediated by vascular smooth muscle cell proliferation
11/12/1996US5574058 Polysubstituted benzimidazoles as antiviral agents
11/12/1996US5574057 Naamidine A extracted from sea sponges and methods for its use as an anti-tumor agent
11/12/1996US5574055 Cognitive and neurodegenerative disorders
11/12/1996US5574053 Method for treating anxiety
11/12/1996US5574052 Agonist-antagonist combination to reduce the use of nicotine and other drugs
11/12/1996US5574051 Hypoglycemic
11/12/1996US5574050 Hydroxyl ions as unique therapeutic agents and processes for preparing them
11/12/1996US5574048 Methods of inhibiting hirsutism and alopecia in women
11/12/1996US5574047 Methods of inhibiting imperfect tissue repair
11/12/1996US5574046 Heteroaryl amines as novel acetylcholinesterase inhibitors
11/12/1996US5574045 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
11/12/1996US5574041 Without neuroleptic effect
11/12/1996US5574039 Antitumor, fungicides
11/12/1996US5574038 5,6-cyclicimidazo [1,5-a] Quinoxalines
11/12/1996US5574037 Modulated by sino-atrial node, antiischemic agent
11/12/1996US5574036 Adamantyl-substituted polycyclic acetylene compounds and pharmaceutical/cosmetic compositions comprised thereof
11/12/1996US5574035 S-timolol hemihydrate composition and method of preparation therefor
11/12/1996US5574034 Treatment of immune diseases and excess cell proliferation, enzyme inhibitors
11/12/1996US5574032 Antipsychotic agents, analgesics
11/12/1996US5574031 Piperazine carboxamides
11/12/1996US5574029 Method for treating anxiety
11/12/1996US5574028 Method for treating anxiety
11/12/1996US5574027 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
11/12/1996US5574026 Methods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growth
11/12/1996US5574024 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
11/12/1996US5574023 Stabilizes the helix conformation, amtitumor
11/12/1996US5574020 Propylene glycol
11/12/1996US5574019 Method of perfusing a primate
11/12/1996US5574017 Inhibit bacterial cell wall biosynthesis
11/12/1996US5573999 Fungicides and insecticides
11/12/1996US5573946 Biologically pure culture of Streptomyces hygroscopicus ATCC 53718 capable of producing antibiotic compounds
11/12/1996US5573924 Novel receptor cytokine, protein
11/12/1996US5573786 Preparation for skin and mucous membrane
11/12/1996US5573781 Injectable fatty acid ester and cytostatic agent
11/12/1996US5573780 Stable solid formulation of enalapril salt and process for preparation thereof
11/12/1996US5573776 Delivery of ergot alkaloids to mouths
11/12/1996US5573775 Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
11/12/1996US5573774 Nicotine metabolites, nicotine dependence and human body weight
11/12/1996US5573765 Composition and method for treatment of vaginal yeast infections
11/12/1996US5573759 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
11/12/1996US5573758 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
11/12/1996US5573757 Viscoelastic compositions containing concentrated fluorinated compounds their method of preparation and their uses
11/12/1996US5573755 Zinc hydroxide or copp hydroxide salt
11/12/1996US5573726 Disinfecting contact lenses
11/12/1996US5573528 Implanting devices for the focal release of neuroinhibitory compounds
11/12/1996CA2174715A1 Seco-d steroids active on the cardiovascular system and pharmaceutical compositions containing same
11/12/1996CA2105302C 1-azabicyclo¬3.2.2.|nonan-3-amine derivatives
11/12/1996CA2069910C Muscarinic receptor antagonists
11/12/1996CA2053711C Compositions useful in inhibiting generation, maturation, motility and viability of sperm with minerals in biovailable form
11/12/1996CA2049655C Pharmaceutical composition for inhibiting platelet aggregation
11/12/1996CA2042534C Treatment and/or a method of treating
11/12/1996CA2040319C Sulfonylamino substituted bicyclyl hydroxamic acid derivatives
11/12/1996CA2039249C Sulfonylphenyl-.beta.-d-thioxylosides, their method of preparation and their use in therapeutics
11/12/1996CA2028440C Naphthyloxazolidone derivatives
11/12/1996CA2017276C Carcinostatic or antitumor antibiotic, conagenin, and production and uses thereof
11/12/1996CA2012295C Pyrrolidine derivatives
11/12/1996CA1338716C Thienyloxyalkylamine derivatives, process for their preparation and medicaments containing them
11/12/1996CA1338712C 3'-deamino-4'-deoxy-4'-amino anthracyclines
11/12/1996CA1338711C Ethanone oximes
11/12/1996CA1338703C Pharmaceutical composition for inhibiting infection with virus causative of acquired human immunodeficiency syndrome
11/12/1996CA1338702C High drug:lipid formulations of liposomal- antineoplastic agents
11/12/1996CA1338700C Subsaturated transdermal delivery device
11/11/1996EP0748792A4 Calcium ketopantothenate with acetylating properties
11/11/1996CA2175985A1 Pharmaceutical composition containing substance inhibiting hsp47 production
11/10/1996CA2175881A1 Vitamin d compounds and methods of preparing these compounds
11/08/1996EP0748793A4 Ketopanthenol with acetylating properties
11/07/1996WO1996035124A1 Modulation of bcl-2 phosphorylation
11/07/1996WO1996034970A1 Improved methods for transfecting t cells
11/07/1996WO1996034957A1 Pancreas-derived serpin
11/07/1996WO1996034956A1 Methods for modulating t cell survival by modulating bcl-xl protein level
1 ... 6861 6862 6863 6864 6865 6866 6867 6868 6869 6870 6871 6872 6873 6874 6875 6876 6877 6878 6879 6880 6881 ... 7860